Cargando…
Testosterone depot injection in male hypogonadism: a critical appraisal
Testosterone compounds have been available for almost 70 years, but the pharmaceutical formulations have been less than ideal. Traditionally, injectable testosterone esters have been used for treatment, but they generate supranormal testosterone levels shortly after the 2- to 3-weekly injection inte...
Autores principales: | Yassin, Aksam A, Haffejee, Mohamed |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686335/ https://www.ncbi.nlm.nih.gov/pubmed/18225458 |
Ejemplares similares
-
Testosterone replacement in male hypogonadism
por: Kalra, Sanjay, et al.
Publicado: (2010) -
Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophrenia
por: Carpiniello, Bernardo, et al.
Publicado: (2016) -
Testosterone replacement therapy improves the health-related quality of life of men diagnosed with late-onset hypogonadism
por: Almehmadi, Yousef, et al.
Publicado: (2016) -
Effects of Long-Term Testosterone Therapy on Patients with “Diabesity”: Results of Observational Studies of Pooled Analyses in Obese Hypogonadal Men with Type 2 Diabetes
por: Haider, Ahmad, et al.
Publicado: (2014) -
Safety and efficacy of testosterone gel in the treatment of male hypogonadism
por: Lakshman, Kishore M, et al.
Publicado: (2009)